Last reviewed · How we verify
pEYS606
At a glance
| Generic name | pEYS606 |
|---|---|
| Sponsor | Eyevensys |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or Panuveitis (PHASE1, PHASE2)
- A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pEYS606 CI brief — competitive landscape report
- pEYS606 updates RSS · CI watch RSS
- Eyevensys portfolio CI